ArticleAntimicrobial agents and chemotherapy1992
Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli isolated in Sweden: a 10-year follow-up report.
Article in Antimicrobial agents and chemotherapy, 1992. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 56 citations in OpenAlex.
- Recurrent Campylobacter jejuni bacteremia in a patient with hypogammaglobulinemia: A case report.Medicine · 2017Article
- Antimicrobial resistance and antimicrobial use associated with laboratory-confirmed cases of Campylobacter infection in two health units in Ontario.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2013Article
- Comparison of broth microdilution, E Test, and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni and Campylobacter coli.Journal of clinical microbiology · 2003Article
- Review
- Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998.Antimicrobial agents and chemotherapy · 2000Article
- Rapid emergence of high-level resistance to quinolones in Campylobacter jejuni associated with mutational changes in gyrA and parC.Antimicrobial agents and chemotherapy · 1998Article
- Purulent pleurisy caused by Campylobacter lari.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 1998Article
- Antimicrobial susceptibility patterns of thermophilic Campylobacter spp. from humans, pigs, cattle, and broilers in Denmark.Antimicrobial agents and chemotherapy · 1997Article
- Indwelling device-related bacteremia caused by serum-susceptible Campylobacter coli.Journal of clinical microbiology · 1997Article
- Infection with ciprofloxacin-resistant Campylobacter jejuni in travellers returning from Asia.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 1996Article
- Antibiotic susceptibility of campylobacter isolates from sewage and poultry abattoir drain water.Epidemiology and infection · 1995Article
- Bactericidal properties of Campylobacter jejuni-specific immunoglobulin M antibodies in commercial immunoglobulin preparations.Antimicrobial agents and chemotherapy · 1995Article
- Temperature-dependent membrane fatty acid and cell physiology changes in coccoid forms of Campylobacter jejuni.Applied and environmental microbiology · 1995Article
- Susceptibilities of fluoroquinolone-resistant strains of Campylobacter jejuni to 11 oral antimicrobial agents.Antimicrobial agents and chemotherapy · 1995Article
- Evolution of susceptibilities of Campylobacter spp. to quinolones and macrolides.Antimicrobial agents and chemotherapy · 1994Article
- Susceptibilities of beta-lactamase-positive and -negative strains of Campylobacter coli to beta-lactam agents.Antimicrobial agents and chemotherapy · 1993Article
- Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.Emerging infectious diseasesArticle
- Integronlike structures in Campylobacter spp. of human and animal origin.Emerging infectious diseasesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Resistance to erythromycin and doxycycline and more recently to fluoroquinolones has been reported to occur in Campylobacter spp. both in vitro and in patients treated with these antibiotics. The frequency of resistance to 14 antimicrobial agents in Campylobacter jejuni and Campylobacter coli isolated from patients infected in Sweden or abroad is described. For some agents, a comparison of susceptibility in strains of Campylobacter spp. isolated in 1978 with those isolated in 1988 is made. No general increase in in vitro resistance to antibiotics commonly used for the treatment of human gastroenteritis caused by C. jejuni or C. coli has occurred during the last 10 years in Sweden, which might be a consequence of strict antibiotic control. The numbers of strains from 1988 to 1989 resistant to ciprofloxacin and to norfloxacin included in this study (0.7 and 1.4%, respectively) are still fewer than those that were resistant to erythromycin (7.3%) or doxycycline (12.4%). There is, however, since 1989 to 1990 an indication of increasing resistance to these antibiotics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.